Science ❯ Clinical Trials
Ameluz PDT Drug Efficacy Efficacy Studies Longitudinal Studies
With global HIV funding dwindling, a Gilead-Global Fund agreement secures two million no-profit lenacapavir doses for low- and middle-income countries.
